Tarsus Pharmaceuticals, Inc. (TARS)
USD 52.7
(-1.05%)
USD 52.7
(-1.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17.44 Million | 25.81 Million | 57.02 Million | - | - | - |
| Cost of Revenue | 1.59 Million | 955 Thousand | 2.07 Million | 246 Thousand | 74 Thousand | 1000.00 |
| Gross Profit | 15.85 Million | 24.86 Million | 54.95 Million | -246 Thousand | -74 Thousand | -1000.00 |
| Operating Expenses | 159.01 Million | 87.57 Million | 67.1 Million | 26.99 Million | 4.29 Million | 1.35 Million |
| Selling, General and Administrative Expenses | 108.7 Million | 44.94 Million | 25.39 Million | 8.17 Million | 1.13 Million | 449 Thousand |
| Research and Development Expenses | 50.31 Million | 42.62 Million | 41.71 Million | 18.82 Million | 3.16 Million | 901 Thousand |
| Other Expenses | - | 86 Thousand | -73 Thousand | - | - | - |
| Cost and Expenses | 160.6 Million | 88.52 Million | 69.18 Million | 26.99 Million | 4.29 Million | 1.35 Million |
| Operating Income | -143.15 Million | -62.71 Million | -12.15 Million | -26.99 Million | -4.29 Million | -1.35 Million |
| Interest Expense | 3.34 Million | 2.19 Million | - | 188 Thousand | 40 Thousand | - |
| Income Tax Expense | - | -4000.00 | 55 Thousand | 1000.00 | 1000.00 | 1000.00 |
| Earnings before Tax | -135.89 Million | -62.09 Million | -13.77 Million | -26.81 Million | -4.66 Million | -1.31 Million |
| Net Income | -135.89 Million | -62.09 Million | -13.82 Million | -26.81 Million | -4.67 Million | -1.31 Million |
| Earnings Per Share Basic | -4.62 | -2.52 | -0.67 | -1.32 | -0.24 | -0.31 |
| Earnings Per Share Diluted | -4.62 | -2.52 | -0.67 | -1.32 | -0.24 | -0.31 |
| Weighted Average Shares Outstanding | 29.38 Million | 24.61 Million | 20.55 Million | 20.32 Million | 19.5 Million | 4.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.38 Million | 24.61 Million | 20.55 Million | 20.32 Million | 19.5 Million | 4.28 Million |
| Gross Margin | 0.91 | 0.96 | 0.96 | - | - | - |
| EBIT Margin | -7.55 | -2.29 | -0.19 | - | - | - |
| Profit Margin | -7.79 | -2.41 | -0.24 | - | - | - |
| EBITDA | -131.67 Million | -59.1 Million | -13.16 Million | -26.56 Million | -4.55 Million | -1.34 Million |
| Earnings Before Tax Margin | -8.21 | -2.43 | -0.21 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 40.81 Million | 27.61 Million | 17.44 Million | 13.07 Million | 1.87 Million | 15.27 Million |
| Cost of Revenue | 3 Million | 1.65 Million | 1.59 Million | 1.21 Million | 377 Thousand | 316 Thousand |
| Gross Profit | 37.8 Million | 25.96 Million | 15.85 Million | 11.86 Million | 1.49 Million | 14.96 Million |
| Operating Expenses | 71.11 Million | 63.64 Million | 159.01 Million | 56.31 Million | 42.42 Million | 32.82 Million |
| Selling, General and Administrative Expenses | 58.79 Million | 51.57 Million | - | 43 Million | 30.32 Million | 20.27 Million |
| Research and Development Expenses | 12.31 Million | 12.06 Million | - | 13.3 Million | 12.1 Million | 12.54 Million |
| Other Expenses | -59 Thousand | 605 Thousand | -102 Thousand | -13 Thousand | -48 Thousand | -47 Thousand |
| Cost and Expenses | 74.11 Million | 65.29 Million | 160.6 Million | 57.52 Million | 42.8 Million | 32.82 Million |
| Operating Income | -33.3 Million | -37.68 Million | -143.15 Million | -44.45 Million | -40.93 Million | -32.82 Million |
| Interest Expense | 2 Million | -983 Thousand | 3.34 Million | 989 Thousand | -858 Thousand | 815 Thousand |
| Income Tax Expense | - | -270 Thousand | 709.1 Thousand | 30.39 Million | -1.78 Million | -27.07 Million |
| Earnings before Tax | -33.29 Million | -35.73 Million | -135.89 Million | -41.9 Million | -40.93 Million | -31.42 Million |
| Net Income | -33.29 Million | -35.73 Million | -135.89 Million | -41.9 Million | -39.14 Million | -31.42 Million |
| Earnings Per Share Basic | -0.88 | -1.01 | - | -1.31 | -1.28 | -1.17 |
| Earnings Per Share Diluted | -0.88 | -1.01 | - | -1.31 | -1.28 | -1.17 |
| Weighted Average Shares Outstanding | 37.82 Million | 35.3 Million | 29.38 Million | 31.94 Million | 30.62 Million | 26.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.82 Million | 35.3 Million | 29.38 Million | 31.94 Million | 30.62 Million | 26.81 Million |
| Gross Margin | 0.93 | 0.94 | 0.91 | 0.91 | 0.80 | 0.98 |
| EBIT Margin | -0.81 | -1.36 | - | -3.37 | -21.88 | -1.99 |
| Profit Margin | -0.82 | -1.29 | -7.79 | -3.20 | -20.92 | -2.06 |
| EBITDA | -33.06 Million | -37.68 Million | - | -44.1 Million | -40.93 Million | -30.46 Million |
| Earnings Before Tax Margin | -0.82 | -1.36 | -8.21 | -3.40 | -21.88 | -2.15 |
DBOEY
ZDPY
5257
AMGY
3636
AEC1